Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Troisdorf – page 2

24 clinical trials in Troisdorf, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Troisdorf at a glance
24
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

24 trials in Troisdorf

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Institut fuer Frauengesundheit GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Trastuzumab Deruxtecan
  • Sponsor:WSG Women's Cancer Study Group GmbH

Ischaemic stroke+2

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Asundexian
  • Sponsor:Bayer AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ribociclib
  • Sponsor:WSG Women's Cancer Study Group GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bleomycin Sulfate
  • Sponsor:University Of Cologne
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:F. Hoffmann-La Roche AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Giredestrant
  • Sponsor:F. Hoffmann-La Roche AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Technische Universitaet Dresden
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Novartis Pharma AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:WSG Women's Cancer Study Group GmbH

Neoplasm malignant

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:NSABP Foundation Inc.

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Troisdorf

What the registry says about research in the country

01 Breast Cancer Research

Extensive clinical trials focusing on triple-negative breast cancer and HER2-positive variants, evaluating innovative therapeutic approaches including immunotherapy and targeted treatments.

  • Early-stage breast cancer treatments
  • Neoadjuvant therapies
  • Hormone receptor-positive studies

Multiple trials investigating personalized treatment approaches and novel drug combinations to improve patient outcomes.

02 Lung Cancer Studies

Research initiatives examining non-small cell lung cancer treatments, with particular emphasis on combining immunotherapy with conventional treatments.

  • Advanced stage treatments
  • Digital patient monitoring
  • Chemoradiotherapy optimization

Innovative approaches including FDG-PET-based therapies and home treatment solutions are being evaluated.

03 Neurological Conditions

Studies focused on preventing ischemic stroke and managing post-stroke complications using novel therapeutic agents.

  • Stroke prevention strategies
  • Antiplatelet therapy research
  • High-risk TIA management

Trials evaluating oral FXIa inhibitors and their efficacy in preventing recurrent strokes.

04 Hematologic Oncology

Advanced research in Hodgkin Lymphoma treatment, comparing different therapeutic regimens to optimize patient outcomes.

  • Reduced toxicity protocols
  • Treatment-related morbidity studies
  • Progressive therapy evaluation

Focus on developing less toxic treatment options while maintaining therapeutic efficacy.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.